Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses

Publication: The Lancet Diabetes and Endocrinology

Christiane Drechsler, Mark J Bolland, Ian Reid, Johann Willeit, Georg Schett, Peter Santer, Reecha Sofat, Julie Taylor, Caroline Dale, Richard L Prince, Yoav Ben-Shlomo, John Gallacher,  Gorm B Jensen, Ruth Frikke-Schmidt, Stig Egil Bojesen, Marianne Benn, Anders B Wulff, Signe V Krogh, Louise Lind Schierbeck, Stephen Kaptoge, Nicholas Wareham, Ben Schöttker, Anna Zhu, Bernd Holleczek, Elaine Dennison, Karen Jameson,
Stefanie Schulze Schleithoff, Sabine Frisch, Allan Linneberg, Tea Skaaby, Line Lund Kårhus, Renate T de Jongh, Marjolein Visser, Harald Dobnig, Cassianne Robinson-Cohen, David S Siscovick, Bryan R Kestenbaum, Alex McConnachie, Naveed Sattar, David Morrison, Annamari Lundqvist, Peggy M Cawthon, Juan R Albertorio, J Wouter Jukema, Stella Trompet, Patricia Kearney, Marcus Dörr, Henry Völzke, Matthias Nauck, Peggy M Cawthon, Peter Rossing, Frederik Persson, Jukka Marniemi, Victoria Vazquez, Johan Sundström, Ulf Risérus,
Karl Michaëlsson, Jonathan Emberson, David Leon, Mika Kivimäki

27 October 2021


Summary

Research has shown a link between higher vitamin D levels and lower mortality risk. However, the link was only observed in people who are vitamin D deficient.

Participants were compared based on their genetic make-up, suggest that taking vitamin D supplements will reduce mortality risk for those with low levels of vitamin D.

View publication

© Copyright - NIHR Cambridge Biomedical Research Centre 2025